Adiponectin is inversely correlated with cardiovascular risk factors such as hypertension, atherosclerosis, dyslipidemia, and hyperglycemia and is a potential therapeutic target for diastolic dysfunction. This evidence concerns the gene ADIPOQ and atherosclerosis.